Daihan Scientific Co., Ltd

Daihan Scientific Co., Ltd

KKRX:131220
3,560.00
KRW
+75.00
(+2.15%)
695.38EPS
9.53P/E
33.54BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
6,247.22
6,000.94
5,944.91
6,441.56
5,771.26
6,377.96
7,419.91
8,527.56
9,218.93
10,099.44
10,407.57
10,277.84
11,816.66
11,849.23
Basic EPS, GAAP
109.35
121
-217
255
142
242
165
237
524
657
543
386
478
472.13
Free Cash Flow per Basic Share
-630.78
328.06
-73.99
493.21
538.61
250.87
187.86
597.27
126.12
200.51
585.6
500.79
746.89
904.99
Dividend per Share
78.34
1.24
5.32
32.3
51.52
61.9
81.2
85.59
87.7
90.4
99.17
99.97
100.55
106.16
Book Value per Share
2,894.15
3,350.9
3,027.18
3,257.93
3,355.36
3,441.37
3,789.52
3,920.9
4,377.83
4,888.61
5,259.66
5,665.69
6,034.91
5,993.19
Tangible Book Value per Share
2,619.09
3,129.1
2,827.17
3,096.48
3,261.82
3,371.19
3,723.32
3,867.98
4,326.49
4,848.34
5,229.43
5,638.93
6,021.88
5,981.61
Basic Weighted Avg Shares
6
7
7
7
7
7
7
7
7
7
7
7
7
7
Sales/Revenue/Turnover
39,657
39,051
41,605
46,071
41,365
47,056
55,165
61,508
66,281
72,280
73,702
71,694
81,118
83,012
Operating Margin (%)
2.99
2.76
-0.37
3.56
4.67
5.51
3.99
5.85
8.85
10
8.37
5.89
6.82
6.72
Depreciation Expense
1,166
1,311
1,422
1,508
1,398
1,330
1,815
1,827
1,552
1,689
1,838
1,840
1,782
1,750
Net Income, GAAP
694
787
-1,519
1,824
1,018
1,785
1,227
1,709
3,767
4,702
3,845
2,693
3,281
3,308
Effective Tax Rate (%)
5.14
1.79
- -
15.56
19
16.42
18.51
10.55
17.81
16.92
18.71
13.77
15.55
15.4
Profit Margin (%)
1.75
2.02
-3.65
3.96
2.46
3.79
2.22
2.78
5.68
6.51
5.22
3.76
4.05
3.98
Working Capital
14,505
13,077
11,830
13,806
14,533
17,571
19,341
19,170
22,961
27,041
29,715
33,282
38,453
38,212
LT Debt
9,974
4,342
2,869
1,397
92
- -
316
202
2,187
2,694
61
244
73
278
Total Equity
18,569
22,139
23,072
25,095
26,029
29,416
32,798
34,620
38,919
44,429
48,695
52,875
56,783
56,551
Return on Invested Capital (%)
3.93
3.29
- -
4.37
5.27
7.49
5.57
9.2
12.29
13.13
9.91
6.73
8.16
8.28
Return on Capital (%)
3.86
3.6
- -
5.01
2.61
3.81
1.71
2.04
6.66
7.19
5.23
2.89
3.24
3.08
Return on Common Equity (%)
3.86
3.98
-7.09
8.11
4.3
7.19
4.55
5.95
12.18
13.62
10.17
6.61
7.53
7.61

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
531
498
824
LT Borrowings
- -
- -
- -
LT Finance Leases
122
73
278
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
7
7
7
Market Capitalization
34,989
35,846
33,536

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
50,670
52,792
51,437
Cash, Cash Equivalents & STI
13,150
16,121
16,190
Accounts Receivable, Net
8,633
8,974
7,155
Inventories
27,128
25,370
26,537
Total Current Liabilities
12,730
14,339
13,225
Payables & Accruals
- -
- -
- -
ST Debt
531
498
824
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.47%
10.43%
7.39%
Free Cash Flow
-44.06%
39.86%
46.77%
Net Income, GAAP
-6.2%
23.77%
21.86%
Sales/Revenue/Turnover
7.22%
5.84%
13.14%
Total Cash Common Dividend
64.97%
2.32%
-1.02%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
13,908
17,620
18,442
21,724
71,694
2025
15,700
19,008
21,211
25,199
81,118
2026
17,595
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
78
76
103
121.38
386
2025
76
150
246
5.97
478
2026
80
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
29.56
63.67
- -
6.58
99.97
2025
32.77
61.45
6.35
- -
100.55
2026
40.63
- -
- -
- -
- -

Company Description

CEO
Hyun-Jeong Seo
Full Time Employees
120
Sector
Health technology
Industry
Medical specialties
Address
Wonju-si South Korea
IPO Date
Sep 19, 2011
Business
Daihan Scientific Co., Ltd. is a South Korea-based company primarily engaged in the development, manufacturing, wholesale distribution, and servicing of laboratory instruments, medical equipment, and scientific research consumables. Founded in 1980 and headquartered in Wonju-si, Gangwon-do, South Korea, the company operates across two principal business divisions: self-manufactured scientific apparatus and comprehensive laboratory supply distribution. The company manufactures and markets equipment under its proprietary DAIHAN and Wisd brands, while distributing laboratory products from approximately 270 domestic and international partners. The company's product portfolio is organized into several primary categories: temperature and environmental control equipment, comprising ultra-low temperature freezers, laboratory autoclaves, forced-convection and natural-convection drying ovens, vacuum ovens, refrigerated and carbon dioxide incubators, muffle furnaces, and temperature-controlled water and oil baths; sample preparation and mixing apparatus, including magnetic stirrers, overhead digital stirrers, vortex mixers, orbital shakers, ultrasonic homogenizers, tissue grinders, hotplates, and refrigerated cooling circulators; analytical and testing instruments, including high-performance liquid chromatography systems, gas chromatographs, spectrophotometers, analytical balances, moisture analyzers, and digital pH meters; and research consumables and laboratory safety apparatus, comprising precision laboratory glassware, reactor systems, fume hoods, biosafety cabinets, liquid handling pipettes, and membrane vacuum pumps. Additionally, the company provides Internet of Things-enabled Smart-Lab systems integrated with full-touchscreen controllers and the WiRe mobile application for real-time remote monitoring, data recording, and self-diagnostic maintenance. Alongside hardware manufacturing, the company delivers Total Lab Care services, encompassing laboratory facility planning, equipment validation, calibration, instrument rental, maintenance, and maintenance, repair, and operations consumables distribution. Daihan Scientific serves a diverse customer base spanning pharmaceutical corporations, biotechnology enterprises, university research institutes, medical centers, government laboratories, and industrial testing facilities throughout South Korea and exports to more than 70 countries across Asia, Europe, the Middle East, and the Americas. The company conducts business through direct operations and affiliate entities, including SciLab Korea Co., Ltd. for precision glassware and reactor systems, DAIHAN Vietnam Co., Ltd., SciLab Malaysia Sdn. Bhd., and regional franchise networks in Indonesia. In recent developments, Daihan Scientific has expanded its global commercial infrastructure through the publication and digital deployment of its worldwide SciLab and Globality catalogs, expanding international distribution channels across Southeast Asian and European markets. The company has accelerated the integration of Internet of Things and cloud-connected automation across its core equipment lines, upgrading its Smart-Lab remote monitoring and self-diagnostic platform to support automated biotechnology workflows. Furthermore, Daihan Scientific has broadened its enterprise maintenance, repair, and operations logistics and one-day delivery fulfillment systems, expanded its specialized pre-owned laboratory equipment portal, and enhanced strategic partnerships with global laboratory instrument manufacturers to strengthen its comprehensive supply and validation capabilities for biopharmaceutical manufacturing and life science research clients.